NSD3
Summary: This gene is related to the Wolf-Hirschhorn syndrome candidate-1 gene and encodes a protein with PWWP (proline-tryptophan-tryptophan-proline) domains. This protein methylates histone H3 at lysine residues 4 and 27, which represses gene transcription. Two alternatively spliced variants have been described. [provided by RefSeq, May 2015].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
nuclear receptor binding SET domain protein 3 | MIM:607083 | Ensembl:ENSG00000147548 | HGNC:HGNC:12767 | PA37370 | 8p11.23 |
GO terms in NSD3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IC | GO:0005634 | nucleus |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IEA | GO:0005694 | chromosome |
BP | IEA | GO:0006351 | transcription, DNA-templated |
BP | IEA | GO:0006355 | regulation of transcription, DNA-templated |
BP | IDA | GO:0016571 | histone methylation |
BP | IEA | GO:0034968 | histone lysine methylation |
MF | IPI | GO:0005515 | protein binding |
MF | IDA | GO:0018024 | histone-lysine N-methyltransferase activity |
MF | TAS | GO:0018024 | histone-lysine N-methyltransferase activity |
MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: NSD3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NSD3
Database | Pathway ID | Pathway Des. |
---|---|---|
kegg | hsa00310 | Lysine degradation - Homo sapiens (human) |
reactome | R-HSA-3214841 | PKMTs methylate histone lysines |
reactome | R-HSA-3247509 | Chromatin modifying enzymes |
reactome | R-HSA-4839726 | Chromatin organization |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD356 | PNU-74654 | 3 |
iGMDRD23 | Gossypol | 2 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD100 | Zebularine | 3 |
iGMDRD577 | BIX01294 | 4 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD318 | PAC-1 | 4 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD802 | 4-methylfasudil | 6 |
iGMDRD255 | SB225002 | 4 |
iGMDRD679 | Bistramide A | 2 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD61 | Kinetin riboside | 7 |
iGMDRD193 | Fqi1 | 4 |
iGMDRD427 | ABT737 | 1 |
iGMDRD670 | ML 210 | 3 |
iGMDRD144 | NSC95397 | 4 |
iGMDRD779 | PRL-3 Inhibitor I | 1 |
iGMDRD781 | Sirolimus | 6 |
iGMDRD433 | Lexibulin | 3 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD300 | Tozasertib | 7 |
iGMDRD353 | PD0325901 | 1 |
iGMDRD414 | MST-312 | 2 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD329 | Merck60 | 3 |
iGMDRD366 | PI-103 | 3 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD267 | Oligomycin A | 4 |
iGMDRD77 | Itraconazole | 3 |
iGMDRD202 | Curcumin | 1 |
iGMDRD901 | ELCPK | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD341 | Triacsin c | 7 |
iGMDRD57 | Chloropentafluorobenzene | 2 |
iGMDRD150 | RITA | 8 |
iGMDRD405 | PIK-75 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NSD3